Skip to main content

Advertisement

Log in

Metal complexes of 1,10-phenanthroline-5,6-dione alter the susceptibility of the yeast Candida albicans to Amphotericin B and Miconazole

  • Published:
Biometals Aims and scope Submit manuscript

Abstract

Growth of the pathogenic yeast Candida albicansin sub-MIC (minimum inhibitory concentration) levels of Cu(ClO4)2 ⋅ 6H2O and [Cu(phendio)3](ClO4)2 ⋅ 4H2O (phendio = 1,10-phenanthroline-5,6-dione) increased the concentration of miconazole and amphotericin B required to achieve the MIC90 whereas pre-growth in AgClO4 and [Ag(phendio)2]ClO4 resulted in a small decrease in the relevant MIC90 values. The copper complexes reduce the oxygen consumption of C. albicans while the silver complexes increase oxygen consumption. In addition, pre-growth of cells in the copper complexes resulted in a lower ergosterol content while the silver complexes induced an elevation in ergosterol synthesis.

The ability of copper and silver complexes to alter the susceptibility of C. albicans to miconazole and amphotericin B may be influenced by their action on respiration, since reduced respiration rates correlate with reduced cellular ergosterol which is the target for amphotericin B. Lower levels of ergosterol have previously been associated with elevated tolerance to this drug. In the case of reduced sensitivity to miconazole, tolerance may be mediated by lower ergosterol synthesis giving rise to fewer toxic side products once biosynthesis is inhibited by miconazole.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abu-Salah KM. 1996 Amphotericin B: an update. Brit J Biomed Sci 53, 122-133.

    Google Scholar 

  • Arthington-Skaggs BA, Warnock DW, Morrison CJ. 1999 Quantitation of ergosterol content: Novel methods for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 37, 3332-3337.

    Google Scholar 

  • Canuto M, Rodero FG. 2002 Antifungal drug resistance to azole and polyenes. Lancet (Infect Dis) 2, 550-562.

    Google Scholar 

  • Coyle B, Kavanagh K, McCann M, Devereux M, Geraghty M. 2003a Mode of anti-fungal activity of 1,10-phenanthroline and its Cu(II), Mn(II) and Ag(I) complexes. Biometals 16, 321-329.

    Google Scholar 

  • Coyle B, Kinsella P, McCann M, Devereux M, O'Connor R, Clynes M, Kavanagh K. 2003b Induction of apoptosis in yeast and mammalian cells by exposure to 1,10-phenanthroline metal complexes. Toxicology in Vitro (in press).

  • Daum G, Lees ND, Bard M, Dickson R. 1998 Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae. Yeast 14, 1471-1510.

    Google Scholar 

  • Geber A, Hitchcock CA, Swartz JE, Pullen FS, Marsden KE, Kwon-Chung KJ, Bennett JE. 1995 Deletion of the Candida glabrata ERG3 and ERG11 genes: Effect on cell viability, cell growth, sterol composition and antifungal susceptibility. Antimicrob Agen Chemother 39, 2708-2717.

    Google Scholar 

  • Geraghty P, Kavanagh K. 2003a Erythromycin, an inhibitor of mitoribosomal protein biosynthesis, alters the Amphotericin B susceptibility of Candida albicans. J Pharm Pharmacol 55, 179-184.

    Google Scholar 

  • Geraghty P, Kavanagh K. 2003b Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of Amphotericin B. Arch Microbiol 179, 295-300.

    Google Scholar 

  • Igdaloff D, Santi DV, Eckert TS, Bruice TC. 1983. Effects of 1,7-and 1,10-phenanthroline dione on tissue culture cells. Biochemical Pharmacol 32, 172-174.

    Google Scholar 

  • Kelly SI, Lamb DC, Kelly DE, Manning NJ, Loeffier J, Herbart H, Schumacher U, Einsele H. 1997 Resistance to fluconazole and cross resistance to amphotericin B in Candida aibicans from AIDS patients caused by defective sterol ?5,6 desaturation. FEBS Letts 400, 80-82.

    Google Scholar 

  • McCann M, Geraghty M, Devereux M et al. 2000 Insights into the mode of action of the anti-Candida activity of 1,10-phenanthroline and its metal chelates. Metal-Based Drugs 7, 185-193.

    Google Scholar 

  • McCann M, Coyle B, McKay S, McCormack P, Kavanagh K, Devereux M, McKee V, Kinsella P, O'Connor R, Clynes M. Synthesis and X-ray crystal structure of [Ag(phendio)2]ClO4 (phendio = 1,10-phenanthroline-5,6-dione) and its effects on fungal and mammalian cells. Biometals (submitted).

  • Morschhauser J. 2002 The genetic basis of fluconazole resistance development in Candida albicans. Biochem Biophys Acta 1587, 240-248.

    Google Scholar 

  • Parks LW, Casey WM. 1995 Physiological implications of sterol biosynthesis in yeast. Ann Rev Microbial 49, 95-116.

    Google Scholar 

  • Vazquez JA, Arganoza MT, Vaishampayan JK, Akins RA. 1996 In vitro interaction between Amphotercin B and azoles in Candida albicans. Antimicrob Agen Chemother 40: 2511-2516.

    Google Scholar 

  • White TC, Marr KA, Bowden RA. 1998 Clinical, cellular and molecular factors that contribute to anti-fungal drug resistance. Clin Microbiol Rev 11: 382-402.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kevin Kavanagh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eshwika, A., Coyle, B., Devereux, M. et al. Metal complexes of 1,10-phenanthroline-5,6-dione alter the susceptibility of the yeast Candida albicans to Amphotericin B and Miconazole. Biometals 17, 415–422 (2004). https://doi.org/10.1023/B:BIOM.0000029438.97990.c6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BIOM.0000029438.97990.c6

Keywords

Navigation